Advertise Your Books with us!
We want to help promote all of your pathology related books. Our standard options are:
(a) $300 for posting a book for 5 years, with your choice of book cover and link and inclusion in appropriate book categories and chapters
(b) $1,000 to add a standard E-blast / social media post
(c) Other options (banners on Home page or in textbook) are also available.
Please contact us to discuss at Ads@PathologyOutlines.com or (248) 646-0325.
Search Books
Books by specialty: oncology - 11 entries found
Mahul Amin, Stephen Edge, Frederick L. Greene, David R. Byrd, Robert K. Brookland, Mary Kay Washington, Jeffrey E. Gershenwald, Carolyn C. Compton, Kenneth R. Hess, Daniel C. Sullivan, J. Milburn Jessup, James D. Brierley, Lauri E. Gaspar, Richard L. Schilsky, Charles M. Balch, David P. Winchester, Elliot A. Asare, Martin Madera, Donna M. Gress, Laura R. Meyer
8th ed., 3rd reprinting, 1024 pages, $114, Springer (2018)
Posted April 19, 2018
Listed under: oncology; Textbook chapters: Staging of tumors
The AJCC Cancer Staging Manual is used by physicians and health care professionals throughout the world to facilitate the uniform description and reporting of neoplastic diseases. Proper classification and staging of cancer is essential for the physician to assign proper treatment, evaluate results of management and clinical trials, and to serve as the standard for local, regional and international reporting on cancer incidence and outcome.
Richard Cote, Ram Datar
359 pages, 2 illus., $209 list, Springer (2016)
Posted December 15, 2015
Listed under: oncology
This volume provides the latest research on circulating tumor cells aimed for cancer researchers, scientists, and molecular oncologists. It presents the basic concepts behind circulating tumor cells (CTCs), metastatic biology, and potential applications as to how CTCs can be used in diagnostic biomarkers.
Jan Trøst Jørgensen
1st ed, 508 pages, $120, Elsevier (2019)
Posted May 4, 2020
Companion and Complementary Diagnostics: From Biomarker Discovery to Clinical Implementation provides readers with in-depth insights into the individual steps in the development of companion diagnostic assays, from the early biomarker discovery phase straight through to final regulatory approval. Further, the clinical implementation of companion diagnostic testing in the clinic is also discussed. As the development of predictive or selective biomarker assays linked to specific drugs is substantially increasing, this book offers comprehensive information on this quickly-evolving area of biomedicine. It is an essential resource for those in academic institutions, hospitals and pharma, and biotech and diagnostic commercial companies.
Il-Jin Kim
1st ed, 270 pages, $108, Other (2019)
Posted May 4, 2020
This book covers the technical, historical, clinical, and regulatory aspects of CDx in precision medicine. Clearly, more and more newly developed oncology drugs will require accompanying CDx assays, and this book, with chapters contributed by renowned oncologists, provides a comprehensive foundation for the knowledge and application of CDx for precision medicine.
David Kerr, Daniel Haller, Cornelis J. H. van de Velde, Michael Baumann, Nagahiro Saijo
3rd ed, 832 pages, $398 list, Oxford (2016)
Posted April 18, 2016
Listed under: oncology
Written and edited by internationally recognized leaders in the field, the new edition of the Oxford Textbook of Oncology has been fully revised and updated, taking into consideration the advancements in each of the major therapeutic areas, and representing the multidisciplinary management of cancer.
Massimo Loda, Lorelei Mucci, Megan Mittelstadt, Mieke Van Hemelrijck, Maura Brid Cotter
1,235 pages, $199 list, Springer (2016)
Posted July 19, 2016
Listed under: oncology
This book integrates the disciplines of cancer pathology and epidemiology to provide a synergistic and complementary approach to understanding the molecular mechanisms of cancer. This book provides relevant information on the diagnostic, prognostic and predictive molecular pathology of cancer. Epidemiological studies, including descriptive epidemiology, risk factors and molecular mechanisms of disease inform on the etiology and progression of cancer.
Louise Hanna, Tom Crosby, Fergus Macbeth
2nd ed, 621 pages, $101 list, Cambridge (2016)
Posted March 4, 2016
Listed under: oncology
Practical Clinical Oncology, 2nd edition, provides a practical and comprehensive review of the current management of common types of cancer. Introductory chapters give background information on the main treatment modalities and other key issues such as acute oncology, palliative care and clinical research, with new chapters on pathology and advanced external beam radiotherapy. Subsequent chapters describe the diagnosis and treatment of malignancies, based on tumour site or type. Finally, multiple choice questions allow the reader to test their knowledge.
Manfred Dietal, Christian Wittekind, Gianni Bussolati and Moritz von Winterfeld
133 pages, 65 illus, $80 list, Springer (2015)
Posted August 31, 2015
Listed under: oncology
This book presents an overview of the most important current developments in the pre-analytical handling of tissue. It addresses in particular potential ways to improve the situation whereby methods employed in the pre-analytical phase – the period from surgical removal of tissue to the start of pathological processing – have remained essentially unchanged for decades with only modest standardization. It is examined how the pre-analytical period can be optimized, resulting not only in an increase in diagnostic quality but also in a reduction in processing time and costs.
Antonio Russo, Rafael Rosell and Christian Rolfo
269 pages, 29 illus, $112 list, Elsevier (2015)
Posted December 31, 2015
Listed under: oncology
This volume provides readers a comprehensive and state-of-the-art overview about the range of applications of targeted therapies for solid tumors. The sections of the book have been structured to review the oncogene addicted tumors, the pharmacology and clinical development of new molecularly targeted agents, the use of biomarkers as prognostic, predictive and surrogate endpoints, and the evaluation of tumor response and specific malignancies treated with targeted agents.
Hagop Kantarjian, Robert A. Wolff
3rd Edition, 1280 pages, $281 list, McGraw-Hill (2016)
Posted October 23, 2018
Listed under: oncology; Textbook chapters: Bone marrow neoplastic
The MD Anderson Manual of Medical Oncology details the personalized multidisciplinary approach to cancer management pioneered by The University of Texas MD Anderson Cancer Center. It is intended to bring a pragmatic approach to cancer management that can serve as a guide for oncologists around the world.
Barry Feig, C. Denise Ching
720 pages, $47, Wolters Kluwer (2018)
Posted November 18, 2019
Listed under: oncology
The sixth edition of the MD Anderson Surgical Oncology Handbook focuses on multidisciplinary, cooperative approaches to issues confronting the surgical oncologist. Organized by disease and in full color for the first time, this volume is comprehensive yet concise, and takes into account all of the oncologic issues you need to consider in order to fully understand each disease and its relevant treatments.
